𝔖 Bobbio Scriptorium

✦ LIBER ✦

When to Conduct a Renal Impairment Study During Drug Development: US Food and Drug Administration Perspective

✍ Scribed by Huang, S-M; Temple, R; Xiao, S; Zhang, L; Lesko, L J

Book ID: 109845778
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 195 KB
Volume: 86
Category: Article
ISSN: 0009-9236
DOI: 10.1038/clpt.2009.190

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renal risks of sodium phosphate tablets

Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the US Food and Drug Administration

✍ E. D. Ehrenpreis; D. Parakkal; R. Semer; H. Du 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Use of the Latent Period in the Assay of

Use of the Latent Period in the Assay of Ergonovine on the Isolated Rabbit Uterus††It is a pleasure to acknowledge the assistance of C. I. Bliss, Connecticut Agricultural Experiment Station, in outlining the method for computing the standard error of the assay, and that of D. C. Grove, Drug Division, Food and Drug Administration, in preparing the ergonovine solutions used in this study.

✍ Vos, Bert J. 📂 Article 📅 1943 🏛 Elsevier ⚖ 340 KB 👁 1 views